BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30453157)

  • 1. Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS/MS method: An application to pharmacokinetic study in Sprague Dawley rats.
    Surendran S; Paul D; Pokharkar S; Choulwar S; Deshpande A; Giri S; Satheeshkumar N
    J Pharm Biomed Anal; 2019 Feb; 164():509-513. PubMed ID: 30453157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of tyrosine kinase inhibitor afatinib in rat plasma using LC-MS/MS and its application to in vivo pharmacokinetic studies of afatinib liposomes.
    Lu X; Liu S; Yang X; Han M; Sun K
    J Pharm Biomed Anal; 2019 Feb; 164():181-186. PubMed ID: 30390560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-ESI-MS/MS determination of defactinib, a novel FAK inhibitor in mice plasma and its application to a pharmacokinetic study in mice.
    Hallur G; Tamizharasan N; Sulochana SP; Saini NK; Zainuddin M; Mullangi R
    J Pharm Biomed Anal; 2018 Feb; 149():358-364. PubMed ID: 29145097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies.
    Edlund H; Lee SK; Andrew MA; Slatter JG; Aksenov S; Al-Huniti N
    Clin Pharmacokinet; 2019 May; 58(5):659-672. PubMed ID: 30556110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-MS/MS determination of flavokawain B, a novel anti-tumor chemotherapeutic agent in rat plasma and its application to a pharmacokinetic study in rats.
    Yang X; Zan T; Yan H; Liu B
    Biomed Chromatogr; 2019 Feb; 33(2):e4391. PubMed ID: 30238480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated LC-MS/MS method for simultaneous determination of linagliptin and metformin in spiked human plasma coupled with solid phase extraction: Application to a pharmacokinetic study in healthy volunteers.
    Abbas Moussa B; Mahrouse MA; Fawzy MG
    J Pharm Biomed Anal; 2019 Jan; 163():153-161. PubMed ID: 30312887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans.
    Podoll T; Pearson PG; Evarts J; Ingallinera T; Bibikova E; Sun H; Gohdes M; Cardinal K; Sanghvi M; Slatter JG
    Drug Metab Dispos; 2019 Feb; 47(2):145-154. PubMed ID: 30442651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of bentysrepinine (Y101) in rat plasma by liquid chromatography tandem mass spectrometry: application to pharmacokinetic study.
    Fan H; Li R; Gu Y; Si D; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():103-9. PubMed ID: 22366283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and selective method for the quantitative analysis of miglitol in rat plasma using unique solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry.
    Mizuno-Yasuhira A; Kinoshita K; Jingu S; Yamaguchi J
    Biomed Chromatogr; 2014 Oct; 28(10):1423-9. PubMed ID: 24706526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid UHPLC-MS/MS method for the quantification of ARQ531 in rat plasma: Validation and its application to a pharmacokinetic study.
    Liu J; Ji M; Li Z; Xu X; Li L; Li H; Tian Y; Su X
    Biomed Chromatogr; 2020 Nov; 34(11):e4937. PubMed ID: 32614971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination and pharmacokinetic study of the novel anti-tumor candidate drug DG-7 in rat plasma by liquid chromatography-tandem mass spectrometry.
    Li J; Liu DD; Ke Y; Guo F; Ding XM; Wang SL; Chen Y; Liu HM; Su YQ; Nan YY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():14-8. PubMed ID: 24780702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of Polyphyllin D and Paris H, two potential antitumor active components in Paris polyphylla by liquid chromatography-tandem mass spectrometry and the application to pharmacokinetics in rats.
    Wu S; Gao W; Qiu F; Man S; Fu S; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():54-60. PubMed ID: 22917593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of LC-MS/MS method for the estimation of β-hydroxy-β-methylbutyrate in rat plasma and its application to pharmacokinetic studies.
    Deshpande P; Jie Z; Subbarayan R; Mamidi VK; Chunduri RH; Das T; Shreeram S
    Biomed Chromatogr; 2013 Feb; 27(2):142-7. PubMed ID: 22623082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive LC-MS/MS-based bioanalytical method for quantification of salviaflaside and rosmarinic acid in rat plasma and its application in a pharmacokinetic study.
    Yang Y; Ying S; Li T; Zhen J; Chen D; Wang J
    Biomed Chromatogr; 2018 Aug; 32(8):e4259. PubMed ID: 29655233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of acotiamide in rat plasma by UHPLC-Q-TOF-MS: method development, validation and application to pharmacokinetics.
    Patel PN; Kalariya PD; Swamy CV; Gananadhamu S; Srinivas R
    Biomed Chromatogr; 2016 Mar; 30(3):363-8. PubMed ID: 26153099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of geniposidic acid in rat plasma by LC-MS/MS and its application to in vivo pharmacokinetic studies.
    Zheng X; Huang XT; Li N; Li YY; Mi SQ; Wang NS; Liu CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():138-42. PubMed ID: 22321407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.